Short-Term Health Care Costs of High-Frequency Spinal Cord Stimulation for the Treatment of Postsurgical Persistent Spinal Pain Syndrome.

التفاصيل البيبلوغرافية
العنوان:	Short-Term Health Care Costs of High-Frequency Spinal Cord Stimulation for the Treatment of Postsurgical Persistent Spinal Pain Syndrome.
المؤلفون:	Rajkumar S; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Venkatraman V; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Yang LZ; Department of Biostatistics, Duke University, Durham, NC, USA., Parente B; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Lee HJ; Department of Biostatistics, Duke University, Durham, NC, USA., Lad SP; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. Electronic address: nandan.lad@duke.edu.
المصدر:	Neuromodulation : journal of the International Neuromodulation Society [Neuromodulation] 2023 Oct; Vol. 26 (7), pp. 1450-1458. Date of Electronic Publication: 2023 Mar 03.
نوع المنشور:	Journal Article
اللغة:	English
بيانات الدورية:	Publisher: Elsevier Country of Publication: United States NLM ID: 9804159 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1403 (Electronic) Linking ISSN: 10947159 NLM ISO Abbreviation: Neuromodulation Subsets: MEDLINE
أسماء مطبوعة:	Publication: 2022- : [New York] : Elsevier Original Publication: Malden, MA : Blackwell Science, c1998-
مواضيع طبية MeSH:	Spinal Cord Stimulation* , Failed Back Surgery Syndrome*/therapy, Humans ; Health Care Costs ; Spine ; Pain, Postoperative ; Spinal Cord ; Treatment Outcome
مستخلص:	Objective: High-frequency spinal cord stimulation (HF-SCS) is a treatment option for postsurgical persistent spinal pain syndrome (type 2 PSPS). We aimed to determine the health care costs associated with this therapy in a nationwide cohort. Materials and Methods: IBM Marketscan® Research Databases were used to identify patients who underwent HF-SCS implantation from 2016 to 2019. Inclusion criteria included prior spine surgery or diagnoses of PSPS or postlaminectomy pain syndrome any time within the two years before implantation. Inpatient and outpatient service costs, medication costs, and out-of-pocket costs were collected six months before implantation (baseline) and one, three, and six months after implantation. The six-month explant rate was calculated. Costs were compared between baseline and six months after implant via Wilcoxon sign rank test. Results: In total, 332 patients were included. At baseline, patients incurred median total costs of $15,393 (Q1: $9,266, Q3: $26,216), whereas the postimplant median total costs excluding device acquisition were $727 (Q1: $309, Q3: $1,765) at one month, $2,840 (Q1: $1,170, Q3: $6,026) at three months, and $6,380 (Q1: $2,805, Q3: $12,637) at six months. The average total cost was reduced from $21,410 (SD $21,230) from baseline to $14,312 (SD $25,687) at six months after implant for an average reduction of $7,237 (95% CI = $3212-$10,777, p < 0.001). The median device acquisition costs were $42,937 (Q1: $30,102, Q3: $65,880). The explant rate within six months was 3.4% (8/234). Conclusions: HF-SCS for PSPS was associated with significant decreases in total health care costs and offsets acquisition costs within 2.4 years. With the rising incidence of PSPS, it will be critical to use clinically effective and cost-efficient therapies for treatment. (Copyright © 2023 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.)
فهرسة مساهمة:	Keywords: Cost analysis; failed back surgery syndrome; high-frequency spinal cord stimulation; persistent spinal pain; postlaminectomy syndrome
SCR Disease Name:	post laminectomy syndrome
تواريخ الأحداث:	Date Created: 20230305 Date Completed: 20231009 Latest Revision: 20231009
رمز التحديث:	20231215
DOI:	10.1016/j.neurom.2023.01.016
PMID:	36872148
قاعدة البيانات:	MEDLINE

الوصف
تدمد:	1525-1403
DOI:	10.1016/j.neurom.2023.01.016